Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
  2. Joyce, M Gordon; Bu, Wei; Chen, Wei-Hung; Gillespie, Rebecca A; Andrews, Sarah F; Wheatley, Adam K; Tsybovsky,Yaroslav; Jensen, Jaime L; Stephens,Tyler; Prabhakaran, Madhu; Fisher, Brian E; Narpala, Sandeep R; Bagchi, Meghna; McDermott, Adrian B; Nabel, Gary J; Kwong, Peter D; Mascola, John R; Cohen, Jeffrey I; Kanekiyo, Masaru
  3. Immunity. 2025, Feb 11; 58(2): 295-308.e5. .
  1. 2.   Genetic variations in CC chemokine receptors and hypertension
  2. Zhang, M. D.; Ardlie, K.; Wacholder, S.; Welch, R.; Chanock, S.; O'Brien, T. R.
  3. American Journal of Hypertension. 2006, Jan; 19(1): 67-72.
  1. 3.   Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression
  2. Daar, E. S.; Lynn, H. S.; Donfield, S. M.; Lail, A.; O'Brien, S. J.; Huang, W.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2005, NOV 1; 192(9): 1597-1605.
  1. 4.   Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis
  2. Brittingham, K. C.; Ruthel, G.; Panchal, R. G.; Fuller, C. L.; Ribot, W. J.; Hoover, T. A.; Young, H. A.; Anderson, A. O.; Bavari, S.
  3. Journal of Immunology. 2005, MAY 1; 174(9): 5545-5552.
  1. 5.   The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users
  2. Duggal, P.; Winkler, C. A.; An, P.; Yu, X. F.; Farzadegan, H.; O'Brien, S. J.; Beaty, T. H.; Vlahov, D.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005 38(5): 584-589.
  1. 6.   Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression
  2. Winkler, C. A.; Hendel, H.; Carrington, M.; Smith, M. W.; Nelson, G. W.; O'Brien, S. J.; Phair, J.; Vlahov, D.; Jacobson, L. P.; Rappaport, J.; Vasilescu, A.; Bertin-Maghit, S.; An, P.; Lu, W.; Andrieu, J. M.; Schachter, F.; Therwath, A.; Zagury, J. F.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2004, DEC 1; 37(4): 1534-1538.
  1. 7.   Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants
  2. Silverberg, M. J.; Smith, M. W.; Chmiel, J. S.; Detels, R.; Margolick, J. B.; Rinaldo, C. R.; O'Brien, S. J.; Munoz, A.
  3. American Journal of Epidemiology. 2004 159(3): 232-241.
  1. 8.   Effects of CCR5-Delta 32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis
  2. Ioannidis, J. P. A.; Contopoulos-Ioannidis, D. G.; Rosenberg, P. S.; Goedert, J. J.; De Rossi, A.; Espanol, T.; Frenkel, L.; Mayaux, M. J.; Newell, M. L.; Pahwa, S. G.; Rousseau, C.; Scarlatti, G.; Sei, S.; Sen, L.; O'Brien, T. R.
  3. Aids. 2003 17(11): 1631-1638.
  1. 9.   Genetic influence of CXCR6 chemokine receptor alleles on PCP- mediated AIDS progression among African Americans
  2. Duggal, P.; An, P.; Beaty, T. H.; Strathdee, S. A.; Farzadegan, H.; Markham, R. B.; Johnson, L.; O'Brien, S. J.; Vlahov, D.; Winkler, C. A.
  3. Genes and Immunity. 2003 4(4): 245-250.
  1. 10.   Population survey of CCR5 Delta 32, CCR5 m303, CCR2b 64I, and SDF1 3 ' A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups
  2. Wang, F. S.; Hong, W. G.; Cao, Y. Z.; Liu, M. X.; Jin, L.; Hu, L. P.; Wang, Z.; Feng, T. J.; Hou, J.; Zhang, B.; Shi, M.; Xu, D. P.; Lei, Z. Y.; Wang, B.; Liu, Z. D.; Ye, J. J.; Peng, L.; Qiu, Y.; Winkler, C.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2003 32(2): 124-130.
  1. 11.   Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells
  2. Cui, Y. H.; Le, Y. Y.; Gong, W. H.; Proost, P.; Van Damme, J.; Murphy, W. J.; Wang, J. M.
  3. Journal of Immunology. 2002 168(1): 434-442.
  1. 12.   Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica
  2. Hisada, M.; Lal, R. B.; Masciotra, S.; Rudolph, D. L.; Martin, M. P.; Carrington, M.; Wilks, R. J.; Manns, A.
  3. Journal of Infectious Diseases. 2002 185(9): 1351-1354.
  1. 13.   Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
  2. Kershaw, M. H.; Wang, G.; Westwood, J. A.; Pachynski, R. K.; Tiffany, H. L.; Marincola, F. M.; Wang, E.; Young, H. A.; Murphy, P. M.; Hwu, P.
  3. Human Gene Therapy. 2002 13(16): 1971-1980.
  1. 14.   Inhibitors of monocyte chemoattractant protein-1/CC ligand 2 and its receptor CCR2
  2. Howard, O. M. Z.; Yoshimura, T.
  3. Expert Opinion on Therapeutic Patents. 2001 11(7): 1147-1151.
  1. 15.   Distinctive Effects of Ccr5, Ccr2, and Ssdf1 Genetic Polymorphisms in Aids Progression
  2. Hendel, H.; Henon, N.; Lebuanec, H.; Lachgar, A.; Poncelet, H.; Caillatzucman, S.; Winkler, C. A.; Smith, M. W.; Kenefic, L.; Obrien, S.; Lu, W.; Andrieu, J. M.; Zagury, D.; Schachter, F.; Rappaport, J.; Zagury, J. F.
  3. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998 19(4): 381-386.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel